The principal brain target of all antipsychotic drugs is the dopamine D 2 receptor; in fact, the older traditional antipsychotics, such as haloperidol, chlorpromazine, pimozide, fluphenazine and ...

Results from a retrospective comparative study did not indicate an increased risk for stroke in typical vs. atypical antipsychotic users in a nonelderly population without dementia. These findings, ...

Management of bipolar disorder (BPD) may require multiple medications, including lithium, anticonvulsants, and antipsychotics (both conventional and atypical). Updated treatment guidelines reflect an ...

Medical evidence suggests that psychiatric drugs known as atypical antipsychotics are effective in reducing symptoms for some off-label conditions, but not others, according to a new RAND Corporation ...

Introduction Mitochondrial dysfunction and disrupted cerebral energy metabolism have been increasingly linked to the pathophysiology of schizophrenia. Preclinical studies suggest that certain atypical ...

ROCKVILLE, Md., Jan 14 /PRNewswire-USNewswire/ -- Patients ages 30 to 74 who took atypical antipsychotics such as risperidone (sold as Risperdal), quetiapine (Seroquel), olanzapine (Zyprexa) and ...

The retrospective cohort study involved a search of Medicaid claims of pediatric patients aged 5 to 20 years who were initiated on atypical antipsychotic medications. Atypical antipsychotic use was ...

A study lead by the Economic Evaluation of Chronic Diseases group of Biogipuzkoa Health Research Institute has revealed the relationship between the use of antipsychotics in dementia and socioeconomic ...

Dr Doraiswamy is concerned that we may have underestimated the effects of past use of typical antipsychotics on pituitary volume in the patients defined as ‘drug-free’ (ie, drug-free for at least 3 ...

Pharmaceutical companies have recently paid out the largest legal settlements in U.S. history — including the largest criminal fines ever imposed on corporations — for illegally marketing ...

Objective: To examine the use and economic cost of antiparkinsonian agents during the medication management of patients diagnosed with schizophrenic disorders in a naturalistic healthcare setting.

Epstein R.A., Bobo W.V., Shelton R.C., Arbogast P.G., Morrow J.A., Cooper W.O. Increasing use of atypical antipsychotics and anticonvulsants during pregnancy ...